VAR News and Press, Varian Medical Systems Inc. From 09/16/19

PALO ALTO, Calif. , Sept. 16, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced its ProBeam 360° proton therapy system is now available in a multi-room configuration. The ProBeam 360° system is the smallest multi-room system available for sale and offers uncompromised c...

PALO ALTO, Calif. , Sept. 15, 2019 /PRNewswire/ -- Strengthening its leadership in delivering innovative new solutions to transform cancer care globally, Varian (NYSE: VAR) today announced Ethos ™  therapy, an Adaptive Intelligence ™  solution. Ethos therapy is an ...

PALO ALTO, Calif. and PHILADELPHIA , Sept. 13, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it is investing in Oncora Medical and partnering to accelerate the development of software tools to enable precision medicine in radiation oncology. Oncora is a privately-held dig...

PALO ALTO, Calif. , Sept. 12, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced its fourth quarter fiscal year 2019 earnings release date. The Company will report results for the fourth quarter of fiscal year 2019 after market close on Wednesday, October 23, 2019 .  The...

AbbVie (NYSE: ABBV ) upgraded to Buy with a $79 (14% upside) price target at UBS. Shares up  2%  premarket. More news on: AbbVie Inc., Seattle Genetics, Inc., Varian Medical Systems, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

September 12, 2019 Palm Beach, FL – September 12, 2019 – When people all around the world hear the name “Mayo Clinic” that usually translates to “the best”. The Mayo Clinic has worked long and hard to deserve that perception, which is enti...

PALO ALTO, Calif. and BEIJING , Sept. 11, 2019 /PRNewswire/ -- Varian (NYSE: VAR) has received notice from the Customs Tariff Commission of the State Council of China that medical linear accelerators are excluded from the additional tariffs China imposed on US products that beg...

PALO ALTO, Calif. , Sept. 10, 2019 /PRNewswire/ -- The New York Proton Center (NYPC) has treated its first proton therapy cancer patients. Equipped with the Varian ProBeam ® proton therapy system, NYPC is New York State's first proton therapy facility and is a collaboration betwee...

PALO ALTO, Calif. , Aug. 28, 2019 /PRNewswire/ -- Varian (NYSE: VAR) has completed the installation of the cyclotron for its ProBeam ®  Compact single-room proton therapy system at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine ...

PALO ALTO, Calif. , Aug. 21, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that Phil Febbo , MD, chief medical officer (CMO) at Illumina has been appointed to the Varian Board of Directors, effective August 16, 2019 . "We are proud to have Phil Febbo join the Varian ...